Skip to main content

Replimune Group, Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

REPL$23.28+4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands)

Three Months Ended June 30,
20262025
Cash flows from operating activities:
Net loss$(69,766)$(86,693)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense7,6748,762
Depreciation and amortization937873
Operating lease, right-of-use-asset amortization206185
Finance lease, right-of-use-asset amortization607607
Net amortization of premiums and discounts on short-term investments(112)(1,339)
Impairment on property, plant and equipment108—
Noncash interest expense806415
Unrealized foreign currency transaction (gains) losses(688)591
Changes in operating assets and liabilities:
Research and development incentives receivable1,3471,631
Prepaid expenses and other current assets3,129234
Accounts payable(2,334)3,765
Accrued expenses and other current liabilities(17,424)(5,536)
Operating lease liabilities(218)(195)
Other non-current liabilities—(316)
Net cash used in operating activities(75,728)(77,016)
Cash flows from investing activities:
Purchases of property, plant and equipment and software capitalization(6)(2,740)
Purchase of short-term investments(9,884)(37,581)
Proceeds from sales and maturities of short-term investments59,883105,369
Net cash provided by investing activities49,99365,048
Cash flows from financing activities:
Principal payment of finance lease obligation(203)(166)
Proceeds from exercise of stock options1,0038
Net cash provided by (used in) financing activities$800$(158)
Effect of exchange rate changes on cash, cash equivalents and restricted cash1,270(1,616)
Net decrease in cash, cash equivalents and restricted cash(23,665)(13,742)
Cash, cash equivalents and restricted cash at beginning of period210,727112,822
Cash, cash equivalents and restricted cash at end of period$187,062$99,080
Supplemental disclosure of cash flow information:
Cash paid during the period for interest1,7751,059
Cash paid for income taxes, net33—
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses3645
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.